| Pharmaceutical active ingredients: |
| Lidocaine HydrochlorideMetamizole |
| Available forms, composition and doses of Duo-Norgesic N: |
| N / A |
| Duo-Norgesic N medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB52 - Metamizole Sodium, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| 3M |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tongill | Lidocaine Hydrochloride; Lysozyme Hydrochloride; Tyrothricin | Novartis |
| Osmogel | Lidocaine Hydrochloride; Magnesium Sulfate | Merck |
| Onctose | Lidocaine Hydrochloride; Mefenidramium Methylsulfate | Merck |
| A.P.R 15 | Lidocaine Hydrochloride; Menthol | Feelgood Nutraceutical; Vanwin Group |
| TPR20 | Lidocaine Hydrochloride; Menthol | Trans Research International Trust |
| Neuro-Fortamin | Lidocaine Hydrochloride; Metamizole | Chiesi |
| Spondylon Injections | Lidocaine Hydrochloride; Metamizole | Wyeth |
| Depo-Medrone with Lidocaine | Lidocaine Hydrochloride; Methylprednisolone | Pfizer |
| Depo-Medrol com Lidocaina | Lidocaine Hydrochloride; Methylprednisolone Acetate | Pfizer |
| Depo-Medrol cum Lidocain | Lidocaine Hydrochloride; Methylprednisolone Acetate | Pfizer |